Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Axsome Therapeutics, Inc.(AXSM) | 2,360,077 | 2,360,077 | 0 | $188.33M | $189.99M | 21.46% | +$1.65M |
| Nuvalent Inc | 1,924,626 | 1,924,626 | 0 | $144.52M | $146.00M | 16.50% | +$1.48M |
| Spyre Therapeutics, Inc.(SYRE) | 378,421 | 4,018,101 | +3,639,680 | $14.35M | $94.47M | 10.67% | +$80.11M |
| Apogee Therapeutics Inc | 2,048,647 | 2,048,647 | 0 | $136.13M | $80.61M | 9.11% | -$55.52M |
| Enliven Therapeutics Inc | 3,202,798 | 3,202,798 | 0 | $56.34M | $74.85M | 8.46% | +$18.51M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,762,837 | 2,762,837 | 0 | $82.89M | $71.50M | 8.08% | -$11.38M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 3,204,841 | +3,204,841 | $0 | $59.83M | 6.76% | +$59.83M |
| Cogent Biosciences, Inc.(COGT) | 4,725,641 | 6,225,641 | +1,500,000 | $31.76M | $52.48M | 5.93% | +$20.73M |
| Astria Therapeutics Inc | 3,554,129 | 3,554,129 | 0 | $50.02M | $32.34M | 3.65% | -$17.68M |
| Protagonist Therapeutics Inc | 931,890 | 931,890 | 0 | $26.96M | $32.29M | 3.65% | +$5.33M |
| Viridian Therapeutics, Inc.(VRDN) | 1,845,813 | 1,845,813 | 0 | $32.32M | $24.01M | 2.71% | -$8.31M |
| Bicycle Therapeutics PlcADS | 0 | 1,069,199 | +1,069,199 | $0 | $21.64M | 2.44% | +$21.64M |
| Terns Pharmaceuticals Inc | 2,040,000 | 748,996 | -1,291,004 | $13.38M | $5.10M | 0.58% | -$8.28M |
| Geron Corporation(GERN) | 6,666,667 | 0 | -6,666,667 | $22.00M | $0 | — | -$22.00M |
| Kiniksa Pharmaceuticals LtdCL A | 3,204,841 | 0 | -3,204,841 | $63.23M | $0 | — | -$63.23M |
| Merus N V | 717,254 | 0 | -717,254 | $32.30M | $0 | — | -$32.30M |
| Tyra Biosciences, Inc.(TYRA) | 1,393,329 | 0 | -1,393,329 | $22.85M | $0 | — | -$22.85M |